FDA approves Cubists' drug for antibiotic-resistant bacteria
December 19, 2014 at 18:07 PM EST
Dec 19 (Reuters) - Cubist Pharmaceutical Inc's drug to treat complicated urinary tract and intra-abdominal infections won U.S. approval on Friday, highlighting the regulator's interest in tackling the growing threat of the so-called superbugs.
